A review of 2014 cancer drug approvals, with a look at 2015 and beyond
- PMID: 25798040
- PMCID: PMC4357352
A review of 2014 cancer drug approvals, with a look at 2015 and beyond
Abstract
The number of cancer medications approved by the Food and Drug Administration has risen steadily in recent years. This article provides a concise overview of drugs and indications added to the cancer armamentarium in 2014 and to date in 2015.
References
-
- CenterWatch. FDA-approved drugs. Available at: https://www.centerwatch.com/drug-information/fda-approved-drugs. Accessed February 18, 2015.
-
- Pharmaceutical Research and Manufacturers of America. Medicines in Development: Cancer—2014 Report. Available at: http://www.phrma.org/sites/default/files/pdf/2014-cancer-report.pdf. Accessed January 12, 2015.
-
- Cyramza (ramucirumab) prescribing information. Indianapolis, Indiana: Eli Lilly and Company; Dec, 2014. Available at: http://pi.lilly.com/us/cyramza-pi.pdf. Accessed December 10, 2014.
-
- Food and Drug Administration. FDA approves Cyramza for stomach cancer. Apr 21, 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm394107.htm. Accessed January 9, 2015.
-
- Food and Drug Administration. FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer. Dec 12, 2014. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426720.htm. Accessed January 9, 2015.
LinkOut - more resources
Full Text Sources